OakChart

Park Ha Biological Technology Co Ltd

BYAHConsumer Defensive·Household & Personal Products·China·Nano·NASD·Nov 11 • 9:52 AM ET

1.49-0.46 (-23.59%)
2026-11-11 15:52 CET
Market cap
4.57 USD m
Revenue, TTM
2.54 USD m
Net income, TTM
-5.45 USD m
Free cash flow, TTM
-0.58 USD m
EPS diluted, TTM
-62.38
P/E
-
Compare

Price

BYAH against its 20, 50 and 200-day averages
2050200
0.0025.0050.0075.00100.008.4M16.8MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26BYAHclose 1.4920-day 2.1850-day 2.36200-day 8.501.49

99.1% under 158.00 on 3 Nov 2025. Last 15 sessions, 149.7% high to low

Profile

BYAH
52-week range, 0% of the way up
1.53120

Park Ha Biological Technology Co. Ltd. is a holding company, which engages in the manufacture of skincare and cosmetic products. It operates through the Product Sales and Franchise Fees segments. The company was founded by Xiao Qiu Zhang on October 11, 2022 and is headquartered in Wuxi, China.

Employees41
IPODec 27, 2024
Beta0.26
ATR, 14d0.40
Rel volume2.80
Short float2.98%
Insider own80.12%
Inst own0.28%

Snapshot

6 groups

Valuation

Index-
Market Cap3.49M
Enterprise Value-1.98M
Income-5.45M
Sales2.54M
Book/sh8.75
Cash/sh2.42
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees41
IPODec 27, 2024

Ratios

P/E-
Forward P/E-
PEG-
P/S1.37
P/B0.17
P/C0.62
P/FCF-
EV/EBITDA-
EV/Sales-0.78
Quick Ratio3.31
Current Ratio3.36
Debt/Eq0.04
LT Debt/Eq0.01
Option/ShortNo / Yes

Earnings

EPS (ttm)-62.38
EPS next Y-
EPS next Q-
EPS this Y-
EPS next Y-
EPS next 5Y-
EPS past 3/5Y- -
Sales past 3/5Y9.57% -
EPS Y/Y TTM76.39%
Sales Y/Y TTM-8.12%
EPS Q/Q99.45%
Sales Q/Q1.49%
Earnings-
EPS/Sales Surpr.- -

Ownership

Insider Own80.12%
Insider Trans0.00%
Inst Own0.28%
Inst Trans9.05%
ROA-81.95%
ROE-113.04%
ROIC-100.03%
Gross Margin87.46%
Oper. Margin-212.16%
Profit Margin-214.17%
SMA20-31.59%
SMA50-36.79%
SMA200-82.46%
Trades-

Technical

Shs Outstand0.57M
Shs Float0.47M
Short Float2.98%
Short Ratio0.08
Short Interest0.01M
52W High120.00 -98.76%
52W Low1.53 -2.61%
Volatility40.25% 14.20%
ATR (14)0.40
RSI (14)30.59
Beta0.26
Rel Volume2.80
Avg Volume183.05K
Volume53,178

Performance

Perf Week-34.07%
Perf Month-37.13%
Perf Quarter-53.00%
Perf Half Y-87.33%
Perf YTD-97.66%
Perf Year-98.76%
Perf 3Y-
Perf 5Y-
Perf 10Y-
Recom-
Target Price-
Prev Close1.95
Price1.49
Change %-23.59%

Peers

Mkt cap
TickerCompanyMkt cap
YSGYatsen Holding Ltd ADR121.80M
BIOTInstinct Bio Technical Company Holdings Inc5.32M
NUSNu Skin Enterprises Inc196.66M
ELEstee Lauder Cos. Inc41.62B
DSYBig Tree Cloud Holdings Ltd14.49M
TANHTantech Holdings Ltd27.77M
SKINSkinHealth Systems Inc106.42M
ATTTAtlas Trinity Tech Ltd12.92M
SLSNSolesence Inc62.17M
JWELJowell Global Ltd4.01M

News

latest 14 of 46
  • Did You Lose Money Investing in Park Ha Biological Technology Co., Ltd.? Robbins LLP Urges Investors to Contact the Firm for Information About Their Rights Against BYAH (Newsfile) +21.93%
  • Park Ha Biological Technology Co., Ltd. Announces Official Approval of Its North American Amazon Store, Launching a New Era of Brand Globalization (GlobeNewswire) -14.68%
  • Park Ha Biological Technology Co., Ltd. Announces Membership Application to Personal Care Products Council (PCPC), Aligning the Brand with International Standards and Marking a Strategic Milestone in its Expansion into Amazon North America (GlobeNewswire) -8.86%
  • Park Ha Biological Technology Co., Ltd. Announces Cooperation with Amazon to Support Its Entry into the North American Personal Care Sector and Accelerate the Implementation of Its Global Strategy (GlobeNewswire)
  • Park Ha Biological Technology Co., Ltd. announces strategic partnership with Cloud Factory Technology Holdings Limited (02512.HK) to build an AI-driven ecosystem for the beauty industry. (GlobeNewswire)
  • Loading…
  • Park Ha Biological Technology Co., Ltd. Announces Closing of $2.0 Million Registered Direct Offering (GlobeNewswire)
  • Park Ha Biological Technology Co., Ltd. Announces Pricing of $2.0 Million Registered Direct Offering (GlobeNewswire) +40.00%
  • Park Ha Biological Launches AI Nutritionist Through Strategic Partnership to Expand AI-Powered Skincare Ecosystem (BYAH) (InvestorsHub)
  • This Microcap Stock Is Up Nearly 170% Pre-Market Today Whats Fueling The Super Rally? (Stocktwits)
  • Park Ha Biological Technology Co., Ltd. announces strategic partnership with Star Plus Legend Group's wholly-owned subsidiary to build an AI-powered skincare and health ecosystem and expand its healthcare reach (GlobeNewswire)
  • Park Ha Biological Technology Co., Ltd. Announces Closing of a US$2.45 Million Public Offering (GlobeNewswire) +12.61% -23.60%
  • Park Ha Biological Technology Co., Ltd. Announces Pricing of US$2.45 Million Best-Efforts Follow-on Public Offering (GlobeNewswire) -24.08%
  • Park Ha Biological Technology Co., Ltd. Announces Nasdaq Ticker Symbol Change to BYAH (GlobeNewswire) +5.39%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
No quarterly earnings.

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
No annual earnings.

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
No estimate revisions.

Estimate history

EPS, annual2.60411.6046.516-331.004
Period2022202320242025
EPS, quarterly
Period
Sales, annual1.9192.4592.3822.525
Period2022202320242025
Sales, quarterly
Period
Shares, annual0.0730.0730.0730.085
Period2022202320242025
Shares, quarterly
Period

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY
Total Revenue2.542.522.382.461.92
Cost of Goods Sold Incl. D&A0.320.140.200.310.51
Gross Profit2.222.382.192.151.41
Selling, General and Administrative Excl. Other7.6226.531.390.971.21
Research and Development0.350.240.040.030.06
Other Operating Expense0.000.000.000.000.00
Operating Income-5.40-24.150.791.180.20
Interest Expense0.000.00--0.00
Unusual Expense0.000.000.000.000.00
Net Income Before Taxes-5.36-24.080.791.180.19
Income Taxes0.090.280.310.33-0.00
Consolidated Net Income-5.45-24.360.480.850.19
Net Income From Continuing Operations-5.45-24.360.480.850.19
Net Income-5.45-24.360.480.850.19
EPS (Recurring)-8.85-331.016.5211.602.60
EPS (Basic, Before Extraordinaries)-62.38-331.006.5211.602.60
EPS (Diluted)-62.38-331.006.5211.602.60
EBITDA-5.21-24.040.821.200.23
Non-Operating Income (Expense)0.040.06-0.000.00-0.01
Other After Tax Adjustments0.000.000.000.000.00
Stock Option Compensation Expense-18.05---
Price To Sales Ratio2.124.37---
Gross Margin87.4694.3691.8087.3573.47
Operating Margin-212.16-956.4533.3248.0110.26
Net Margin-214.17-965.0020.0934.659.97
Shares Outstanding0.620.080.070.070.07
Market Capitalization4.574.574,377.96--

Income statement, quarterly

Currency USD, millions
Metric2026S12025S22025S12024S22024S12023S22023S1
Total Revenue1.261.291.241.530.851.091.37
Cost of Goods Sold Incl. D&A0.140.180.060.100.100.190.13
Gross Profit1.121.111.181.430.750.901.25
Selling, General and Administrative Excl. Other2.085.5420.900.730.660.400.57
Research and Development0.140.210.030.020.020.010.02
Other Operating Expense0.000.000.000.000.000.000.00
Operating Income-0.96-4.43-19.720.700.090.510.67
Interest Expense4E-060.002E-05----
Unusual Expense0.000.000.000.000.000.000.00
Net Income Before Taxes-0.93-4.43-19.660.700.090.500.68
Income Taxes-0.010.100.180.270.040.150.18
Consolidated Net Income-0.92-4.53-19.840.430.050.350.50
Net Income From Continuing Operations-0.92-4.53-19.840.430.050.350.50
Net Income-0.92-4.53-19.840.430.050.350.50
EPS (Recurring)-1.49-60.89-270.115.850.674.806.81
EPS (Basic, Before Extraordinaries)-1.49-60.89-270.115.850.664.806.80
EPS (Diluted)-1.49-60.89-270.115.850.664.806.80
EBITDA-0.87-4.34-19.700.710.100.520.68
Non-Operating Income (Expense)0.030.010.06-0.000.00-0.000.00
Stock Option Compensation Expense-3.0914.96----
Price To Earnings Ratio--98,929.1997,063.90---
Price To Sales Ratio2.124.41151.96----
Gross Margin88.7986.1695.2893.6488.5082.9090.89
Operating Margin-76.53-344.83-1,591.0045.8710.8346.5049.20
Net Margin-73.01-352.26-1,600.7128.105.7332.3936.44
Shares Outstanding0.620.080.070.070.070.070.07
Market Capitalization4.575,075.74151,072.56148,224.13---

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY
Cash & Short Term Investments3.790.551.030.57
Short Term Receivables1.301.110.711.53
Inventories0.080.090.100.10
Other Current Assets0.330.010.140.00
Total Current Assets5.501.761.982.21
Net Property, Plant & Equipment0.340.170.070.06
Total Investments and Advances0.000.000.000.00
Long-Term Note Receivable-0.000.000.18
Intangible Assets0.010.010.010.01
Deferred Tax Assets0.080.06--
Other Assets0.021.090.210.06
Total Assets5.953.082.272.52
Short Term Debt Incl. Current Port. of LT Debt0.100.020.020.03
Accounts Payable0.010.020.200.13
Income Tax Payable1.010.700.350.00
Other Current Liabilities0.760.780.672.21
Total Current Liabilities1.881.521.242.37
Long Term Debt0.080.050.010.00
Provision for Risks Charges0.000.000.000.00
Other Liabilities0.000.000.000.00
Total Liabilities1.961.581.252.37
Non-Equity Reserves0.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.00
Common Equity3.991.511.010.15
Total Shareholders Equity3.991.511.010.15
Accumulated Minority Interest0.000.000.000.00
Total Equity3.991.511.010.15
Total Liabilities & Stockholders Equity5.953.082.272.52
Book Value Per Share47.1720.5113.792.05
Tangible Book Value Per Share47.0920.4113.681.93
Full-Time Employees41312534
Price to Book Ratio0.221,029.99--
Return on Assets-539.2917.8935.62-
Return on Equity-885.8438.00146.43-
Return on Invested Capital-598.5330.7083.33126.87
Quick Ratio2.881.091.510.89
Current Ratio2.921.151.590.93

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY
Net Income-5.45-24.360.480.850.19
Depreciation0.190.110.020.020.03
Other Funds (Non Cash)4.8424.460.230.200.05
Funds from Operations-0.520.180.711.040.27
Extraordinary Item0.000.000.000.000.00
Changes in Working Capital0.24-0.090.25-0.911.17
Income Taxes Payable0.230.370.400.440.08
Cash from Operating Activities-0.270.090.960.131.44
Capital Expenditures-0.31-0.09-0.09-0.02-0.01
Net Assets From Acquisitions0.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.00
Purchase or Sale of Investments-5.020.000.000.000.00
Purchase of Investments-5.020.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.00
Other Uses-4.02-7.13-1.26-0.33-1.60
Other Sources6.686.650.841.380.06
Cash from Investing Activities-2.67-0.57-0.511.02-1.55
Cash Dividends Paid0.000.000.000.000.00
Change in Capital Stock2.153.73-0.890.040.53
Repurchase of Common Pref Stock0.000.000.000.000.00
Sale of Common Pref Stock2.153.73-0.890.040.53
Proceedsfrom Stock Options2.153.73-0.890.040.53
Issuance or Reduction of Debt, Net0.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.00
Net Financing Active Other Cash Flow-0.010.01-0.07-0.720.14
Other Financing Activities Uses-0.00-0.07-0.78-0.26
Cash from Financing Activities2.143.74-0.96-0.680.67
Exchange Rate Effect0.08-0.010.02-0.01-0.06
Net Change in Cash-0.723.24-0.490.460.50
Free Cash Flow-0.58-0.000.870.101.43
Preferred Dividends (Cash Flow)-0.000.000.000.00
Deferred Taxes & Investment Tax Credit--0.03-0.02-0.03-0.00

Balance sheet, quarterly

Currency USD, millions
Metric2026S12025S22025S12024S22024S12023S2
Cash & Short Term Investments5.663.791.350.550.931.03
Short Term Receivables0.931.304.161.110.700.71
Inventories0.120.080.070.090.100.10
Other Current Assets0.080.330.000.010.100.14
Total Current Assets6.785.505.581.761.831.98
Net Property, Plant & Equipment0.480.340.180.170.050.07
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets0.010.010.010.010.010.01
Deferred Tax Assets0.160.080.060.06--
Other Assets0.030.020.001.090.250.21
Total Assets7.465.955.833.082.142.27
Short Term Debt Incl. Current Port. of LT Debt0.130.100.030.020.020.02
Accounts Payable0.010.010.020.020.060.20
Income Tax Payable1.111.010.870.700.400.35
Other Current Liabilities0.760.760.610.780.590.67
Total Current Liabilities2.021.881.521.521.071.24
Long Term Debt0.060.080.060.050.000.01
Other Liabilities0.000.000.000.000.000.00
Total Liabilities2.071.961.581.581.071.25
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity5.393.994.251.511.071.01
Total Shareholders Equity5.393.994.251.511.071.01
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity5.393.994.251.511.071.01
Total Liabilities & Stockholders Equity7.465.955.833.082.142.27
Book Value Per Share8.7547.1757.8820.5114.5413.79
Tangible Book Value Per Share8.7447.0957.7820.4114.4313.68
Price to Book Ratio0.221,035.5295,086.3293,293.49--
Return on Assets-81.95-539.29-486.8217.89--
Return on Equity-113.04-885.84-729.7738.00--
Return on Invested Capital-16.86-111.25-459.8627.564.5634.45
Quick Ratio3.312.883.631.091.621.51
Current Ratio3.362.923.681.151.711.59

Cash flow, quarterly

Currency USD, millions
Metric2026S12025S22025S12024S22024S12023S2
Net Income-0.92-4.53-19.840.430.050.35
Depreciation0.100.090.020.010.010.01
Other Funds (Non Cash)0.334.5119.950.180.040.06
Funds from Operations-0.570.050.130.610.100.41
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital0.45-0.210.120.32-0.07-0.25
Income Taxes Payable0.080.150.220.320.080.19
Cash from Operating Activities-0.11-0.160.250.930.030.16
Capital Expenditures-0.23-0.09-0.00-0.08-0.00-0.02
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments-5.020.000.000.000.000.00
Purchase of Investments-5.020.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses-0.57-3.44-3.69-0.77-0.50-0.22
Other Sources0.466.220.430.520.32-0.02
Cash from Investing Activities-5.352.69-3.26-0.33-0.18-0.26
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock2.24-0.103.83-0.890.00-0.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock2.24-0.103.83-0.890.00-0.00
Proceedsfrom Stock Options2.24-0.103.83-0.890.00-0.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow-0.01-0.000.01-0.110.04-0.07
Other Financing Activities Uses-0.01---0.070.00-0.02
Cash from Financing Activities2.24-0.103.83-0.990.04-0.07
Exchange Rate Effect0.070.00-0.010.010.01-0.05
Net Change in Cash-3.162.440.80-0.38-0.10-0.22
Free Cash Flow-0.34-0.250.240.850.030.13
Price to Free Cash Flow--386.30---

Revenue breakdown

Franchise Fees2024: 1.67M 2025: 1.51M
Product Sales Franchisees2024: 351.40K 2025: 478.27K
Products Sales Nonfranchisees2024: 355.83K 2025: 535.76K
China2024: 2.38M 2025: 2.52M
Franchise Fees2024: 1.67M 2025: 1.51M
Product Sales2024: 707.23K 2025: 1.01M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-302.98%0.0M0.5M415.44K
2026-10-156.29%0.0M0.5M443.34K
2026-09-304.74%0.0M0.5M563.64K
2026-09-157.23%0.0M0.5M577.17K
2026-08-319.55%0.0M0.5M892.79K
2026-08-140.98%0.0M2.3M895.24K
2026-07-310.27%0.0M4.2M602.62K
2026-07-150.97%0.0M0.5M575.56K
2026-06-3010.21%0.0M0.3M391.15K
2026-06-15106.49%0.1M0.1M333.79K
2026-05-291.32%0.0M0.1M11.52K
2026-05-152.75%0.0M0.1M12.64K
2026-04-302.42%0.0M0.1M38.77K
2026-04-154.21%0.0M0.1M43.37K
2026-03-313.95%0.0M0.1M42.35K
2026-03-136.83%0.0M0.1M41.01K
2026-02-270.16%0.0M1.5M32.51K
2026-02-1311.42%0.0M0.0M31.20K
2026-01-304.57%0.0M0.0M4.63K
2026-01-152.29%0.0M0.0M627

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-09-116-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-11SEC
2026-09-026-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-02SEC
2026-08-13SCHEDULE 13GSEC
2026-08-10SCHEDULE 13GSEC
2026-08-10SCHEDULE 13GSEC
2026-08-10SCHEDULE 13GSEC
2026-08-10SCHEDULE 13GSEC
2026-08-10SCHEDULE 13GSEC
2026-08-10SCHEDULE 13GSEC
2026-08-10SCHEDULE 13GSEC
2026-08-103Initial statement of beneficial ownership of securities2026-08-03SEC
2026-08-074Statement of changes in beneficial ownership of securities2026-08-03SEC
2026-08-036-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-03SEC
2026-08-03S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-08-036-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-03SEC
2026-07-246-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-04-30SEC
2026-07-136-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-13SEC
2026-07-066-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-06SEC
2026-07-066-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-06SEC
2026-07-016-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-01SEC
2026-06-296-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-29SEC
2026-06-236-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-23SEC
2026-06-156-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-15SEC
2026-06-15424B5SEC
2026-06-126-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-12SEC
2026-06-126-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-12SEC
2026-06-08EFFECTEffectiveness filing by commission orderSEC
2026-06-046-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-04SEC
2026-06-04F-3/ASEC
2026-05-19F-3/ASEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
Virtu Financial LLC0.47%
MORGAN STANLEY0.41%
UBS Group AG0.04%
Caitong International Asset Management Co., Ltd0.00%
ROYAL BANK OF CANADA0.00%

Funds

Fund% owned
Fidelity Nasdaq Composite Index Fund0.00%

OakChart. BYAH. Cached 15 minutes.

Some panels did not load: ratings, insider.